Anthera Pharmaceuticals, Inc. (ANTH)

Anthera Pharmaceuticals Statistics

Total Valuation

Anthera Pharmaceuticals has a market cap or net worth of 26.

Market Cap	26
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Anthera Pharmaceuticals has 26.18 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	26.18M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+68.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.30

Current Ratio	3.30
Quick Ratio	3.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -568.85% and return on invested capital (ROIC) is -559.32%.

Return on Equity (ROE)	-568.85%
Return on Assets (ROA)	-141.96%
Return on Capital (ROIC)	-559.32%
Revenue Per Employee	n/a
Profits Per Employee	-1.19M
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-63.15
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.93
Average Volume (20 Days)	5,555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.14

Income Statement

Revenue	n/a
Gross Profit	-28.26M
Operating Income	-36.80M
Pretax Income	-23.39M
Net Income	-24.93M
EBITDA	-36.40M
EBIT	-36.80M
Earnings Per Share (EPS)	-1.76

Balance Sheet

Cash & Cash Equivalents	8.09M
Total Debt	n/a
Net Cash	8.09M
Net Cash Per Share	0.31
Equity (Book Value)	5.46M
Book Value Per Share	0.21
Working Capital	6.09M

Cash Flow

Operating Cash Flow	-31.95M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Anthera Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-152.23%
Shareholder Yield	-152.23%
Earnings Yield	-95,888,461.54%
FCF Yield	n/a

Stock Splits

The last stock split was on May 1, 2017. It was a reverse split with a ratio of 0.125.

Last Split Date	May 1, 2017
Split Type	Reverse
Split Ratio	0.125

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a